/PRNewswire/ TiumBio Co., Ltd. (Kosdaq: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics.
Allschwil, Switzerland, May 16, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal.
3U Group delivers sound uptrend in Q1 2024, as expected marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
EQS-News: ENCAVIS AG: finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
EQS-News: ENCAVIS AG / Key word: Quarterly / Interim Statement/Forecast
ENCAVIS AG:
03.05.2024 / 10:12 CET/CEST
The issuer is solely responsible for the content of.